Position in DRUG
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$2,408
New position
Shares Held
33
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 93 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GAMMA Investing LLC holds $15,891,706 across 254 Biotechnology names. DRUG ranks #209 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,592 | $2,943,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,507 | $1,937,008 | |
| 3 | MRNA |
Moderna, Inc.
|
15,297 | $777,087 | |
| 4 | INCY |
Incyte Corp
|
7,261 | $683,405 | |
| 5 | TECH |
BIO-TECHNE Corp
|
10,065 | $525,996 | |
| 6 | EXEL |
Exelixis, Inc.
|
9,582 | $410,971 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
12,465 | $345,280 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994 | $328,884 |
All Filings in DRUG
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,408 | 33 | Shares | Defined | 2026-04-06 | |
| No filing history on record for this holder in this stock. | ||||||